UNSPSC 51262302: Fiduxosin

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C30H29N5O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W9O92HYT6I, chemically known as 8-phenyl-3-(4-((3ar,9br)-1,3a,4,9b-tetrahydro-9-methoxy(1)benzopyrano(3,4-c)pyrrol-2(3h)-yl)butyl)pyrazino(2,3:4,5)thieno(3,2-d)pyrimidine-2,4(1h,3h)-dione. but generally known as fiduxosin, which bears US NIH Compound Identifier 172307.

UNSPSC 51262302 Fiduxosin is a Commodity code with minimal recent state and local procurement activity tied directly to the pharmaceutical product itself. The recent opportunities tagged under this code do not reflect purchases of fiduxosin specifically; instead, they show state and local health agencies soliciting naloxone, drug deactivation systems, and broader prescription fulfillment programs through pharmacy benefit arrangements. The mismatch between the code's nominal scope and the actual work being bought suggests this code sees little relevant recent activity in state and local procurement.

Seminole County, Florida posted an IFB (solicitation IFB60459723LAS) in June 2026 for naloxone and safe drug deactivation systems with a response deadline of July 26, 2023, targeting quarterly deliveries to its community health building. The Texas Health and Human Services Commission issued an RFI (HHS0017013) in April 2026 seeking vendor information on direct-to-manufacturer prescription programs and pharmacy benefit arrangements. Neither solicitation targets fiduxosin as a line item or represents typical procurement under this Commodity code. No other recent state and local opportunities appear in the source block, and the geographic and issuing-body patterns are too sparse to characterize meaningful market activity under this code. Business development professionals should verify whether this code accurately reflects their target market, as the recent activity suggests procurement offices are tagging broader pharmaceutical and health-services categories differently.